Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 12:34 AM
Study NCT ID:
NCT03540160
Status:
TERMINATED
Last Update Posted:
2021-05-20
First Post:
2018-04-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Sponsor:
Vyne Therapeutics Inc.
Organization:
Study Overview
Official Title:
An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus
Status:
TERMINATED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No longer pursuing development of serlopitant
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of the long term safety of serlopitant for the treatment of pruritus in adults.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2017-004211-40 | EUDRACT_NUMBER | None | View |